Nanjing, China · Founded 2012 · Privately Held (backing)
Manufacturer of in vitro diagnostic kits designed for early detection of liver cancer in patients with chronic hepatitis B and cirrhosis. SYSDIAGNO is based in Nanjing, China and was founded in 2012. It has raised $14.8 million.
Last price · $/share
—
Implied valuation
—
Total raised
$14.8M
Last round
—
Team — not yet on record
No current team members for SYSDIAGNO are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of SYSDIAGNO with a free account
·Watch SYSDIAGNO: the Monday email on marks, rounds and moves
